High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma

Gerd Jomrich, Matthias Paireder, Ivan Kristo, Andreas Baierl, Ayseguel Ilhan-Mutlu, Matthias Preusser, Reza Asari, Sebastian F. Schoppmann

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Pages (from-to)532-541
Number of pages10
JournalAnnals of Surgery
Volume273
Issue number3
DOIs
Publication statusPublished - Mar 2021

Austrian Fields of Science 2012

  • 301904 Cancer research
  • 101015 Operations research

Keywords

  • esophageal cancer
  • gastroesophageal adenocarcinoma
  • neoadjuvant treatment
  • systemic immune inflammation index (SII)

Cite this